Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
Z Megyesfalvi, CM Gay, H Popper… - CA: a cancer journal …, 2023 - Wiley Online Library
Small cell lung cancer (SCLC) is characterized by rapid growth and high metastatic capacity.
It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority …
It has strong epidemiologic and biologic links to tobacco carcinogens. Although the majority …
Small-cell lung cancer
CM Rudin, E Brambilla, C Faivre-Finn… - Nature Reviews Disease …, 2021 - nature.com
Small-cell lung cancer (SCLC) represents about 15% of all lung cancers and is marked by
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
an exceptionally high proliferative rate, strong predilection for early metastasis and poor …
[HTML][HTML] A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization …
The classification of neuroendocrine neoplasms (NENs) differs between organ systems and
currently causes considerable confusion. A uniform classification framework for NENs at any …
currently causes considerable confusion. A uniform classification framework for NENs at any …
[HTML][HTML] Lung neuroendocrine neoplasms: recent progress and persistent challenges
N Rekhtman - Modern Pathology, 2022 - Elsevier
This review summarizes key recent developments relevant to the pathologic diagnosis of
lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC) …
lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC) …
[HTML][HTML] Best practices recommendations for diagnostic immunohistochemistry in lung cancer
Y Yatabe, S Dacic, AC Borczuk, A Warth… - Journal of thoracic …, 2019 - Elsevier
Since the 2015 WHO classification was introduced into clinical practice,
immunohistochemistry (IHC) has figured prominently in lung cancer diagnosis. In addition to …
immunohistochemistry (IHC) has figured prominently in lung cancer diagnosis. In addition to …
Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung
Cancer (SCLC) provide recommended management for patients with SCLC, including …
Cancer (SCLC) provide recommended management for patients with SCLC, including …
NCCN guidelines insights: small cell lung cancer, version 2.2018
The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease
management. These NCCN Guidelines Insights focus on recent updates to the NCCN …
management. These NCCN Guidelines Insights focus on recent updates to the NCCN …
Small-cell lung cancer
The incidence and mortality of small-cell lung cancer worldwide make this disease a notable
health-care issue. Diagnosis relies on histology, with the use of immunohistochemical …
health-care issue. Diagnosis relies on histology, with the use of immunohistochemical …
Pathology and classification of SCLC
MG Raso, N Bota-Rabassedas, II Wistuba - Cancers, 2021 - mdpi.com
Simple Summary Small cell lung carcinoma (SCLC), is a high-grade neuroendocrine
carcinoma defined by its aggressiveness, poor differentiation, and somber prognosis. This …
carcinoma defined by its aggressiveness, poor differentiation, and somber prognosis. This …